MEZAVANT Trademark

Trademark Overview

On Friday, November 13, 2015, a trademark application was filed for MEZAVANT with the United States Patent and Trademark Office. The USPTO has given the MEZAVANT trademark a serial number of 86819911. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 1, 2023. This trademark is owned by NOGRA PHARMA LIMITED. The MEZAVANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, aminosalicylic acid in capsule, granule, tablet, suppository or enema forms suitable for the treatment of gastrointestinal diseases
mezavant

General Information

Serial Number86819911
Word MarkMEZAVANT
Filing DateFriday, November 13, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 1, 2023
Registration Number5202679
Registration DateTuesday, May 16, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, aminosalicylic acid in capsule, granule, tablet, suppository or enema forms suitable for the treatment of gastrointestinal diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOGRA PHARMA LIMITED
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressDublin 2
IE
Party NameNOGRA PHARMA LIMITED
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressDublin 2
IE
Party NameNOGRA PHARMA LIMITED
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressDublin 2
IE

Trademark Events

Event DateEvent Description
Friday, December 1, 2023CANCELLED SEC. 8 (6-YR)
Monday, May 16, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 4, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 4, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 16, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, February 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 26, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, January 23, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 23, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 23, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 5, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 5, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 5, 2017NON-FINAL ACTION E-MAILED
Thursday, January 5, 2017NON-FINAL ACTION WRITTEN
Thursday, January 5, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, January 3, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 20, 2016SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, December 19, 2016ASSIGNED TO LIE
Tuesday, June 7, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, June 7, 2016LETTER OF SUSPENSION E-MAILED
Tuesday, June 7, 2016SUSPENSION LETTER WRITTEN
Friday, June 3, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, June 1, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 1, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 1, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 2, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 2, 2015NON-FINAL ACTION E-MAILED
Wednesday, December 2, 2015NON-FINAL ACTION WRITTEN
Wednesday, December 2, 2015ASSIGNED TO EXAMINER
Wednesday, November 18, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 17, 2015NEW APPLICATION ENTERED

Related Keywords

mezavant forms enema suitable treatment diseases gastrointestinal suppository tablet namely preparations